Huge market opportunity with their treatment offeringSepsis kills more than twice as many people worldwide as was once believed with 1 in 5 suffering dying of the blood infection. Currently there are 0 approved treatments for biofilms which account for 65% of all bacterial infections that can lead to sepsis. $ASEP may have the first-to-market treatment and rapid diagnosis - huge potential upside all around.